- Home
- OSUR vs JCE Comparison
OSUR vs JCE Comparison
Compare OSUR & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- JCE
- Stock Information
- Founded
- OSUR 2000
- JCE 2007
- Country
- OSUR United States
- JCE United States
- Employees
- OSUR N/A
- JCE N/A
- Industry
- OSUR Medical/Dental Instruments
- JCE Trusts Except Educational Religious and Charitable
- Sector
- OSUR Health Care
- JCE Finance
- Exchange
- OSUR Nasdaq
- JCE Nasdaq
- Market Cap
- OSUR 223.0M
- JCE 235.3M
- IPO Year
- OSUR 1986
- JCE N/A
- Fundamental
- Price
- OSUR $2.81
- JCE $14.98
- Analyst Decision
- OSUR Hold
- JCE
- Analyst Count
- OSUR 1
- JCE 0
- Target Price
- OSUR $3.00
- JCE N/A
- AVG Volume (30 Days)
- OSUR 749.5K
- JCE 49.7K
- Earning Date
- OSUR 05-07-2025
- JCE 01-01-0001
- Dividend Yield
- OSUR N/A
- JCE 9.26%
- EPS Growth
- OSUR N/A
- JCE N/A
- EPS
- OSUR N/A
- JCE N/A
- Revenue
- OSUR $161,626,000.00
- JCE N/A
- Revenue This Year
- OSUR N/A
- JCE N/A
- Revenue Next Year
- OSUR $6.87
- JCE N/A
- P/E Ratio
- OSUR N/A
- JCE N/A
- Revenue Growth
- OSUR N/A
- JCE N/A
- 52 Week Low
- OSUR $2.36
- JCE $11.64
- 52 Week High
- OSUR $4.98
- JCE $14.28
- Technical
- Relative Strength Index (RSI)
- OSUR 51.01
- JCE 56.58
- Support Level
- OSUR $2.71
- JCE $14.77
- Resistance Level
- OSUR $3.01
- JCE $15.22
- Average True Range (ATR)
- OSUR 0.16
- JCE 0.29
- MACD
- OSUR 0.05
- JCE -0.02
- Stochastic Oscillator
- OSUR 68.46
- JCE 55.93
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.